Search companies

Live

Tuesday, 17 November 2026 · 564 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

Compumedics Launches Five-Program Push to Unlock Value From Medical Technology

CMP: $0.250 +4.17% · MC: $48M

Compumedics is pursuing partnerships, licensing, co-development and strategic investment across five programs focused on Somfit, DWL and OrionMEG, aiming to accelerate commercialisation of its existing research and development; it says no transaction has been agreed and none is certain to proceed. The investor update also says the first Somfit D shipment to the US occurred in November, while the company acknowledges it missed FY26 revenue and EBITDA guidance. In FY27, Compumedics is targeting double-digit sales growth and EBITDA growth faster than sales.

Source announcements: 2026-11-11 09:04 to 2026-11-11 09:04 Sydney time
Story updated 2026-11-11 09:57 Sydney time
SourcesInvestor Update Nov-26
Comments